drugset / Trial / NCT01652664
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the intraocular pressure (IOP)-lowering efficacy of Travoprost 0.004% POLYQUAD (PQ) ophthalmic solution compared to Timolol ophthalmic solution (0.5% or 0.25%) in pediatric glaucoma patients.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Timolol | Other / unclassified | 0.25 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |
| Subject | Travoprost | Other / unclassified | 0.004 % | Other |